vs
Nuvation Bio Inc.（NUVB）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是Nuvation Bio Inc.的1.2倍（$50.3M vs $41.9M），Nuvation Bio Inc.同比增速更快（633.1% vs -14.2%）
Nuvation Bio Inc.是一家临床阶段生物制药公司，专注于研发肿瘤靶向治疗药物，以满足难治性癌症领域未被满足的医疗需求，核心管线包含多款针对关键致癌通路的创新候选药物，核心业务及市场主要布局于北美地区。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
NUVB vs RDI — 直观对比
营收规模更大
RDI
是对方的1.2倍
$41.9M
营收增速更快
NUVB
高出647.2%
-14.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.9M | $50.3M |
| 净利润 | — | $-2.6M |
| 毛利率 | — | — |
| 营业利润率 | -81.3% | -1.9% |
| 净利率 | — | -5.1% |
| 营收同比 | 633.1% | -14.2% |
| 净利润同比 | — | -14.5% |
| 每股收益（稀释后） | $-0.11 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NUVBRDI
| Q4 25 | $41.9M | $50.3M | ||
| Q3 25 | $13.1M | $52.2M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | — | $40.2M | ||
| Q4 24 | $5.7M | $58.6M | ||
| Q3 24 | — | $60.1M | ||
| Q2 24 | — | $46.8M | ||
| Q1 24 | $0 | $45.1M |
净利润NUVBRDI
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-55.8M | $-4.2M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | — | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | — | $-7.0M | ||
| Q2 24 | — | $-12.8M | ||
| Q1 24 | $-14.8M | $-13.2M |
毛利率NUVBRDI
| Q4 25 | — | — | ||
| Q3 25 | 74.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率NUVBRDI
| Q4 25 | -81.3% | -1.9% | ||
| Q3 25 | -430.1% | -0.6% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | -17.2% | ||
| Q4 24 | -944.5% | 2.6% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | -16.4% | ||
| Q1 24 | — | -16.7% |
净利率NUVBRDI
| Q4 25 | — | -5.1% | ||
| Q3 25 | -425.2% | -8.0% | ||
| Q2 25 | — | -4.4% | ||
| Q1 25 | — | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -11.7% | ||
| Q2 24 | — | -27.4% | ||
| Q1 24 | — | -29.4% |
每股收益（稀释后）NUVBRDI
| Q4 25 | $-0.11 | $-0.11 | ||
| Q3 25 | $-0.16 | $-0.18 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | $0.00 | $-0.11 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.57 | ||
| Q1 24 | $-0.07 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $529.2M | $10.5M |
| 总债务越低越好 | $47.2M | $185.1M |
| 股东权益账面价值 | $305.7M | $-18.2M |
| 总资产 | $594.8M | $434.9M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资NUVBRDI
| Q4 25 | $529.2M | $10.5M | ||
| Q3 25 | $549.0M | $8.1M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | $502.7M | $12.4M | ||
| Q3 24 | — | $10.1M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | $597.0M | $7.5M |
总债务NUVBRDI
| Q4 25 | $47.2M | $185.1M | ||
| Q3 25 | $47.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NUVBRDI
| Q4 25 | $305.7M | $-18.2M | ||
| Q3 25 | $325.9M | $-12.1M | ||
| Q2 25 | — | $-7.7M | ||
| Q1 25 | — | $-8.1M | ||
| Q4 24 | $463.8M | $-4.4M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | $594.0M | $18.0M |
总资产NUVBRDI
| Q4 25 | $594.8M | $434.9M | ||
| Q3 25 | $601.6M | $435.2M | ||
| Q2 25 | — | $438.1M | ||
| Q1 25 | — | $441.0M | ||
| Q4 24 | $540.6M | $471.0M | ||
| Q3 24 | — | $495.7M | ||
| Q2 24 | — | $494.9M | ||
| Q1 24 | $613.1M | $494.9M |
负债/权益比NUVBRDI
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.7M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | — | $4.1M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.9M |
8季度趋势，按日历期对齐
经营现金流NUVBRDI
| Q4 25 | $-29.7M | $4.3M | ||
| Q3 25 | $-52.9M | $295.0K | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $-7.7M | ||
| Q4 24 | $-46.3M | $8.0M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $-10.4M | ||
| Q1 24 | $-15.7M | $-2.8M |
自由现金流NUVBRDI
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $-246.0K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $-8.0M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $-10.6M | ||
| Q1 24 | — | $-4.7M |
自由现金流率NUVBRDI
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -19.8% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | -1.8% | ||
| Q2 24 | — | -22.7% | ||
| Q1 24 | — | -10.4% |
资本支出强度NUVBRDI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 4.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NUVB
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
